Yokoyama Akira, Kamada Yoko, Imazeki Hiromi, Hayashi Emiko, Murata Shigenori, Kinoshita Kenji, Yokoyama Tetsuji, Kitagawa Yoshinori
National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Kanagawa, Japan.
Suntory Business Expert Limited, Suntory World Research Center, Soraku-gun, Kyoto, Japan.
Alcohol Clin Exp Res. 2016 Jun;40(6):1241-50. doi: 10.1111/acer.13073. Epub 2016 Apr 18.
The genetic polymorphisms of alcohol dehydrogenase-1B (ADH1B) and aldehyde dehydrogenase-2 (ALDH2) are associated with the risk of alcoholism and upper aerodigestive tract cancer in alcoholics. Salivary ethanol (sEtOH) levels are well correlated with blood EtOH levels.
To study the effects of ADH1B and ALDH2 genotypes on the alcohol elimination rate (AER) and salivary acetaldehyde (sAcH) levels, we measured the sEtOH and sAcH levels twice at a 1-hour intervals in 99 intoxicated Japanese alcoholic men who had stopped drinking for 4 or more hours.
The initial sEtOH levels did not differ between the ADH1B2 group (n = 50) and the ADH1B1/1 group (n = 49) (median: 0.617 vs. 0.762 mg/ml). The salivary AER (sAER) increased as the sEtOH levels increased (p < 0.0001). After stratification according to the sEtOH levels (<0.4, 0.4 to 0.99, and ≥1.00 mg/ml), the median sAER of the ADH1B2 group was 0.075, 0.188, and 0.228 mg/ml/h, respectively, and that of the ADH1B1/1 group was 0.037, 0.115, and 0.233 mg/ml/h, respectively. The sAER of the ADH1B2 group was faster than that of the ADH1B1/1 group overall (p = 0.001) and when the sEtOH category was 0.4 to 0.99 mg/ml (p < 0.0001). The ADH1B genotype and the sEtOH levels had an interaction effect on the sAER (p = 0.036). A multiple linear regression analysis with a stepwise procedure selected the ADH1B2 allele (p = 0.004) and the sEtOH levels (p < 0.0001) as positive predictors of sAER. The sAER did not differ according to the ALDH2 genotype. The sAcH levels were higher than the blood AcH levels reported in alcoholics, probably because of AcH production by oral microorganisms. The sAcH of the ALDH2*1/2 group (n = 18) was higher than that of the ALDH21/1 group (n = 81) overall (p = 0.0008) and when the corresponding sEtOH category was ≥1.00 mg/ml (median: 3.195 vs. 1.776 μg/ml, p = 0.009). A multiple linear regression analysis selected the ALDH21/*2 and the sEtOH levels as positive predictors of the sAcH levels (p < 0.0001).
The enhanced AER in ADH1B2 carriers and the increased sAcH levels in ALDH21/*2 carriers among intoxicated alcoholics provide possible mechanisms explaining how each genetic polymorphism affects the risk of alcoholism and upper aerodigestive tract cancer.
乙醇脱氢酶-1B(ADH1B)和乙醛脱氢酶-2(ALDH2)的基因多态性与酒精成瘾风险以及酗酒者上消化道癌症风险相关。唾液乙醇(sEtOH)水平与血液乙醇(EtOH)水平密切相关。
为研究ADH1B和ALDH2基因型对酒精清除率(AER)和唾液乙醛(sAcH)水平的影响,我们对99名已戒酒4小时或更长时间的醉酒日本男性酗酒者每隔1小时测量两次sEtOH和sAcH水平。
ADH1B2组(n = 50)和ADH1B1/1组(n = 49)的初始sEtOH水平无差异(中位数:0.617对0.762mg/ml)。唾液AER(sAER)随sEtOH水平升高而增加(p < 0.0001)。根据sEtOH水平(<0.4、0.4至0.99和≥1.00mg/ml)分层后,ADH1B2组的sAER中位数分别为0.075、0.188和0.228mg/ml/h,ADH1B1/1组分别为0.037、0.115和0.233mg/ml/h。总体上,ADH1B2组的sAER快于ADH1B1/1组(p = 0.001),当sEtOH类别为0.4至0.99mg/ml时也是如此(p < 0.0001)。ADH1B基因型和sEtOH水平对sAER有交互作用(p = 0.036)。采用逐步法的多元线性回归分析选择ADH1B2等位基因(p = 0.004)和sEtOH水平(p < 0.0001)作为sAER的正向预测因子。sAER根据ALDH2基因型无差异。sAcH水平高于酗酒者报告的血液AcH水平,可能是由于口腔微生物产生AcH。总体上,ALDH2*1/2组(n = 18)的sAcH高于ALDH21/1组(n = 81)(p = 0.0008),当相应的sEtOH类别≥1.00mg/ml时也是如此(中位数:3.195对1.776μg/ml,p = 0.009)。多元线性回归分析选择ALDH21/*2和sEtOH水平作为sAcH水平的正向预测因子(p < 0.0001)。
醉酒酗酒者中ADH1B2携带者的AER增强以及ALDH21/*2携带者的sAcH水平升高,为解释每种基因多态性如何影响酒精成瘾风险和上消化道癌症风险提供了可能的机制。